Condition
Refractory Depression
Total Trials
5
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
40%
2 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (2)
P 1 (1)
P 3 (1)
P 4 (1)
Trial Status
Unknown2
Completed1
Suspended1
Active Not Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT06303739Phase 3Active Not RecruitingPrimary
Psilocybin-Assisted Therapy in Treatment-Resistant Depression
NCT04504175Phase 4Completed
Ketamine for Older Adults Pilot
NCT04489082Not ApplicableUnknownPrimary
Near-Infrared Laser Stimulation for Various Neurological Conditions
NCT04202770Not ApplicableSuspendedPrimary
Focused Ultrasound and Exosomes to Treat Depression, Anxiety, and Dementias
NCT04153812Phase 1UnknownPrimary
Clinical Study on the Safety and Effectiveness of Vagus Nerve Stimulation in the Treatment of Refractory Depression
Showing all 5 trials